Brave Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,200
| Closed | -$48K | – | 202 |
|
|
2016
Q3 | $48K | Buy |
+1,200
| New | +$48K | 0.03% | 220 |
|
|
2016
Q2 | – | Sell |
-1,200
| Closed | -$35K | – | 409 |
|
|
2016
Q1 | $35K | Hold |
1,200
| – | – | 0.02% | 250 |
|
|
2015
Q4 | $32K | Buy |
+1,200
| New | +$32K | 0.02% | 259 |
|
|
2015
Q3 | – | Sell |
-1,200
| Closed | -$28K | – | 429 |
|
|
2015
Q2 | $28K | Hold |
1,200
| – | – | 0.02% | 282 |
|
|
2015
Q1 | $28K | Hold |
1,200
| – | – | 0.02% | 281 |
|
|
2014
Q4 | $25K | Sell |
1,200
-4,800
| -80% | -$100K | 0.02% | 289 |
|
|
2014
Q3 | $102K | Hold |
6,000
| – | – | 0.08% | 167 |
|
|
2014
Q2 | $86K | Hold |
6,000
| – | – | 0.06% | 182 |
|
|
2014
Q1 | $74K | Hold |
6,000
| – | – | 0.06% | 183 |
|
|
2013
Q4 | $66K | Buy |
+6,000
| New | +$66K | 0.05% | 193 |
|